Proteus mirabilis
% resistance to tobramycin per hospital
All clinical specimens
(July - December 2022)

Hospital	Medical Wards						Surgical Wards						ICU
	%pmi/total isolates	Isolates tested	%NS	%R	%I		%pmi/total isolates	Isolates tested	%NS	%R	%I		%pmi/total isolates	Isolates tested	%NS	%R	%I
GR001	4.4%	14	35.7	35.7	0.0		2.9%	9	11.1	11.1	0.0		1.9%	1
*GR011	2.7%	16	6.3	6.3	0.0								0.5%	1
GR014	3.6%	51	13.7	13.7	0.0		8.1%	26	7.7	7.7	0.0		2.1%	8	25.0	25.0	0.0
GR018	3.0%	3					3.8%	2					2.0%	2
GR024	4.2%	40	25.0	25.0	0.0		2.6%	7	28.6	28.6	0.0		2.1%	3
GR026	6.1%	16	37.5	37.5	0.0		2.9%	3
GR028	3.9%	53	7.5	7.5	0.0		3.3%	5					4.7%	4
GR030	1.2%	5					1.3%	1					0.5%	1
GR031	5.6%	6
GR032	7.7%	20	40.0	40.0	0.0		7.1%	5					1.4%	1
GR035	3.7%	23	0.0	0.0	0.0		3.2%	8	0.0	0.0	0.0		1.1%	3
GR037	5.9%	71	46.5	46.5	0.0		0.8%	2					2.5%	5
GR039	4.9%	54	48.1	48.1	0.0		4.9%	24	54.2	54.2	0.0		3.7%	23	65.2	65.2	0.0
GR040	5.1%	64	23.4	23.4	0.0		4.4%	26	19.2	19.2	0.0		2.0%	8	25.0	25.0	0.0
GR041	3.0%	13	30.8	30.8	0.0		2.2%	5					1.2%	3
GR046	1.3%	2											2.8%	3
GR047	4.6%	48	31.3	31.3	0.0		5.3%	35	37.1	37.1	0.0
GR048	10.1%	7	14.3	14.3	0.0		3.0%	2
GR049	6.2%	19	26.3	26.3	0.0		7.5%	12	16.7	16.7	0.0		2.7%	4
GR050	4.3%	20	25.0	25.0	0.0		7.6%	23	21.7	21.7	0.0		2.0%	3
GR052	3.9%	6					3.9%	3
GR056	2.3%	8	50.0	50.0	0.0		3.9%	8	0.0	0.0	0.0		1.1%	2
GR062	4.5%	26	50.0	23.1	26.9		4.2%	11	9.1	0.0	9.1		1.4%	2
GR064							11.1%	1
GR070	5.0%	78	30.8	30.8	0.0		4.7%	35	34.3	34.3	0.0		1.9%	5
GR076	6.0%	98	42.9	42.9	0.0		3.7%	17	41.2	41.2	0.0		2.4%	9	44.4	44.4	0.0
GR079	5.6%	8	12.5	0.0	12.5
GR080	6.4%	22	36.4	36.4	0.0		5.5%	16	6.3	6.3	0.0		1.3%	3
GR082	1.8%	22	45.5	36.4	9.1		2.4%	24	25.0	4.2	20.8		1.9%	10	30.0	30.0	0.0
GR083	5.5%	13	38.5	38.5	0.0		5.6%	12	8.3	8.3	0.0		1.9%	6
														5
Weighted Average	4.5%	833	30.9	29.7	1.2		4.0%	324	24.4	22.5	1.9		2.5%	115	45.2	45.2	0.0
Hospital Mean			31.0	29.1	1.9				20.0	18.2	1.9				37.9	37.9	0.0
* Children's Hospital